ELUCIDATING NOVEL FUNGAL METABOLITES

Drug-resistant organisms and the overuse of pesticides is a global threat to our existence.  At IÖN™, we are about to realize a paradigm shift in the biotech industry with our patent-pending technology design to elucidate novel metabolites for patient and target-specific pathogens on demand in as little as 12-24 hours in-vitro as well as in third world applications utilizing off-the-grid production systems. Our goal is to provide trusted pharmaceutical and agricultural industries, including humanitarian agencies, with disruptive technologies that can enhance the quality of life for individuals and the environment world-wide. We are currently modeling robotic and laboratory delivery systems to scale cutting-edge solutions that were previously thought impossible.